From: Quality of life is associated with physical activity and fitness in cystic fibrosis
A. Baseline | Â | Â | Â | Â | Â | Â | Â | Â |
---|---|---|---|---|---|---|---|---|
 | BMI | Body fat | FEV1 | Reported activity | Measured MVPA | Muscle power | Wmax | VO2peak |
Physical functioning | 0.098 | –0.08 | 0.264* | 0.2 | 0.118 | 0.320** | 0.237* | 0.369** |
Vitality | 0.055 | –0.043 | –0.034 | 0.213 | 0.012 | 0.304** | 0.145 | 0.201 |
Emotional state | 0.014 | –0.092 | 0.024 | 0.184 | 0.035 | 0.176 | 0.153 | 0.204 |
Social limitations | –0.033 | 0.082 | –0.066 | 0.212 | –0.182 | –0.031 | 0.06 | 0.059 |
Role limitations | 0.03 | –0.207 | 0.176 | 0.292* | 0.222 | 0.296* | 0.195 | 0.315* |
Feelings of embarrassment | 0.065 | 0.148 | 0.161 | 0.155 | 0.021 | –0.051 | 0.072 | 0.174 |
Body image | 0.435*** | 0.306** | 0.217 | –0.029 | 0.068 | –0.171 | 0.092 | 0.164 |
Eating disturbances | 0.373** | 0.117 | 0.141 | –0.006 | 0.111 | 0.034 | 0.167 | 0.297* |
Treatment burden | 0.096 | –0.027 | 0.046 | 0.066 | –0.134 | 0.137 | 0.211 | 0.177 |
Health perception | 0.18 | –0.023 | 0.283* | 0.187 | 0.163 | 0.13 | 0.284* | 0.396*** |
Weight problems | 0.491*** | 0.228* | 0.147 | –0.073 | 0.012 | –0.08 | 0.350** | 0.456*** |
Respiratory symptoms | 0.027 | 0.114 | 0.302** | 0.106 | 0.057 | 0.041 | 0.204 | 0.424*** |
Digestive symptoms | 0.057 | –0.074 | 0.096 | 0.099 | 0.183 | 0.245* | 0.307** | 0.376** |
B. Changes over 6Â months | Â | Â | Â | Â | Â | Â | Â | Â |
 | Δ BMI | Δ Body fat | Δ FEV1 | Δ Reported activity | Δ Measured MVPA | Δ Muscle power | Δ Wmax | Δ VO 2 peak |
Δ Physical functioning | –0.013 | 0.02 | 0.026 | 0.044 | –0.198 | 0.012 | 0.056 | 0.114 |
Δ Vitality* | 0.189 | 0.16 | 0.094 | 0.227 | –0.16 | 0.057 | 0.305* | 0.176 |
Δ Emotional state | 0.154 | 0.174 | 0.073 | –0.027 | –0.143 | 0.097 | 0.137 | 0.002 |
Δ Social limitations | –0.134 | 0.075 | 0.1015 | –0.027 | –0.11 | 0.051 | 0.13 | 0.243 |
Δ Role limitations | 0.123 | –0.078 | –0.077 | 0.393** | 0.124 | 0.192 | 0.307* | 0.267 |
Δ Feelings of embarrassment | 0.109 | 0.035 | 0.244* | 0.389** | 0.037 | –0.025 | 0.219 | 0.255* |
Δ Body image | 0.1 | 0.139 | 0.148 | 0.195 | 0.012 | 0.178 | –0.028 | 0.02 |
Δ Eating disturbances | 0.066 | 0.19 | 0.21 | 0.089 | 0.091 | 0.171 | 0.067 | 0.048 |
Δ Treatment burden | 0.133 | 0.029 | –0.053 | –0.094 | –0.073 | 0.019 | 0.158 | 0.043 |
Δ Health perception | 0.325** | 0.156 | 0.191 | –0.049 | –0.24 | –0.054 | 0.137 | 0.247* |
Δ Weight problems | 0.545*** | 0.19 | 0.162 | 0.345** | –0.189 | –0.125 | 0.340** | 0.366** |
Δ Respiratory symptoms | 0.177 | 0.015 | 0.205 | 0.069 | –0.112 | –0.104 | 0.041 | 0.112 |
Δ Digestive symptoms | –0.04 | –0.081 | 0.027 | –0.012 | –0.039 | –0.066 | 0.056 | –0.004 |